stockrow
Friday 6 November 2026
Export SHC’s income statement to Excel — free account
Sotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
15.74
0.13
−0.82%
Follow SHC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 7 | 8 | 7 |
+8 more TTM periods Free account |
| 27.03% | 27.78% | 22.73% | 15.42% | ||
| 5.28% | 5.01% | 3.72% | 2.46% | ||
ROIC |
9.80% | 9.82% | 9.38% | 9.07% | |
Return on Tangible Assets |
10.35% | 10.33% | 7.74% | 5.22% | |
Average Days of Receivables |
48.03 | 47.61 | 44.07 | 46.21 | |
Free Cash Flow per Share |
0.47 | 0.39 | 0.34 | 0.53 | |
Free Cash Flow |
135.43 | 112.70 | 96.84 | 149.18 | |
Capital Expenditures |
(196.15) | (179.49) | (164.27) | (138.02) | |
| Other line items | |||||
Cash ROIC |
4.00% | 3.46% | 3.06% | 4.68% | |
Accounts Receivable Turnover |
7.77 | 7.93 | 8.59 | 7.91 | |
Accounts Payable Turnover |
7.92 | 6.65 | 7.25 | 7.79 | |
Inventory Turnover |
11.22 | 9.42 | 8.98 | 10.01 | |
Average Days of Payables |
52.05 | 67.33 | 52.62 | 54.93 | |
Days of Inventory on Hand |
32.46 | 37.57 | 39.45 | 38.31 | |
Tax Rate |
(0.37) | (0.38) | (0.43) | (0.47) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.98% | 21.15% | 21.69% | 21.72% | |
Share Based Compensation of Revenue |
3.00% | 3.05% | 3.20% | 2.65% | |
Interest Coverage |
2.90 | 2.78 | 2.55 | 2.32 | |
Operating CF/Net income |
1.91 | 1.79 | 2.22 | 3.68 | |
Depreciation/Fixed assets |
0.11 | 0.11 | 0.12 | 0.13 | |
Capex/Depreciation |
(1.45) | (1.37) | (1.24) | (0.97) | |
Revenue per Share |
4.30 | 4.26 | 4.17 | 4.10 | |
Operating CF per Share |
1.16 | 1.02 | 0.92 | 1.01 | |
Capex per Share |
(0.69) | (0.63) | (0.58) | (0.49) | |
Capex to Sales |
0.16 | 0.15 | 0.14 | 0.12 |
Columns are period end dates · fundamentals updated 5 Nov 2026